Aspen Neuroscience and Bambusa Therapeutics launch US IPOs
Aspen Neuroscience and Bambusa Therapeutics launched U.S. initial public offerings, Reuters reported.
Story updates
06:50:59 PM UTC
SquawkNews
Drug developers Aspen Neuroscience and Bambusa Therapeutics launched their US initial public offering roadshows on Monday, adding to a wave of issuers from the biotech industry that have tapped the fall IPO window.The sector has been a bright spot in an otherwise lackluster fall IPO window this yea…